Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06398366 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Study acronym: CASPR
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 23, 2025 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Eligibility criteria revisedv3 See this version in full on ClinicalTrials.gov ↗
  2. Notable Primary endpoints revised (3)v2 See this version in full on ClinicalTrials.gov ↗
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.
Trial Details
NCT Number NCT06398366
Lead Sponsor The Cooper Health System
Collaborators: Duke University, Covenant Health, Canada, University of Colorado, Denver, Medical University of South Carolina, University of Maryland, Baltimore, University of Pennsylvania, Emory University, University of Chicago, University of Tennessee, Ohio State University, West Virginia University, Mayo Clinic, Boston Medical Center, Rhode Island Hospital, Beth Israel Lahey Health, Christiana Care Health Services, Henry Ford Health System, Thomas Jefferson University, University of Iowa, University of California, Los Angeles, Allina Health System, Yale University, The University of Texas Health Science Center, Houston, Dartmouth-Hitchcock Medical Center, Virginia Commonwealth University
Conditions Cryptogenic Stroke
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov